Alzheimer’s Disease as a Membrane Disorder: Spatial Cross-Talk Among Beta-Amyloid Peptides, Nicotinic Acetylcholine Receptors and Lipid Rafts

Acetylcholine Receptors ◽

Beta Amyloid ◽

Nicotinic Acetylcholine ◽

Amyloid Peptides

On the Interaction of β-Amyloid Peptides and α7-Nicotinic Acetylcholine Receptors in Alzheimer’s Disease

Current Alzheimer Research ◽

10.2174/15672050113109990132 ◽

2013 ◽

Vol 10 (6) ◽

pp. 618-630 ◽

Cited By ~ 37

Author(s):

Murat Oz ◽

Dietrich Lorke ◽

Keun-Hang Yang ◽

Georg Petroianu

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Acetylcholine Receptors ◽

Nicotinic Acetylcholine ◽

Amyloid Peptides

α7-Nicotinic Acetylcholine Receptors and β-Amyloid Peptides in Alzheimer’s Disease

Nicotinic Acetylcholine Receptor Technologies - Neuromethods ◽

10.1007/978-1-4939-3768-4_10 ◽

2016 ◽

pp. 171-205 ◽

Cited By ~ 1

Author(s):

Dietrich E. Lorke ◽

Georg Petroianu ◽

Murat Oz

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Acetylcholine Receptors ◽

Nicotinic Acetylcholine ◽

Amyloid Peptides ◽

Α7 Nicotinic Acetylcholine Receptors ◽

Β Amyloid

P4-251: BETA AMYLOID OLIGOMER INTERNALIZATION VIA α7β2 NICOTINIC ACETYLCHOLINE RECEPTORS MAY CONTRIBUTE TO CHOLINERGIC CELL DEATH IN ALZHEIMER'S DISEASE

Alzheimer s & Dementia ◽

10.1016/j.jalz.2018.07.073 ◽

2006 ◽

Vol 14 (7S_Part_29) ◽

pp. P1542-P1542

Author(s):

Grace Williams ◽

Teresa A. Murray

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Cell Death ◽

Acetylcholine Receptors ◽

Beta Amyloid ◽

Nicotinic Acetylcholine ◽

Cholinergic Cell ◽

Amyloid Oligomer

Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease

European Journal of Pharmacology ◽

10.1016/s0014-2999(00)00093-5 ◽

2000 ◽

Vol 393 (1-3) ◽

pp. 165-170 ◽

Cited By ~ 156

Author(s):

Alfred Maelicke ◽

Edson X Albuquerque

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Treatment Strategy ◽

Acetylcholine Receptors ◽

Allosteric Modulation ◽

PET Imaging of the α4β2* Nicotinic Acetylcholine Receptors in Alzheimer’s Disease

PET and SPECT in Neurology ◽

10.1007/978-3-642-54307-4_11 ◽

2014 ◽

pp. 255-269

Author(s):

Osama Sabri ◽

Philipp M. Meyer ◽

Hermann-Josef Gertz ◽

Peter Brust ◽

Henryk Barthel ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Pet Imaging ◽

Acetylcholine Receptors ◽

A Role for Nicotinic Acetylcholine Receptors in Alzheimer's Disease

Science Signaling ◽

10.1126/stke.2003.197.tw330 ◽

2003 ◽

Vol 2003 (197) ◽

pp. tw330-tw330

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Acetylcholine Receptors ◽

Preclinical experiments on cognition enhancement in Alzheimer's disease: Drugs affecting nicotinic acetylcholine receptors

Drug Development Research ◽

10.1002/ddr.10086 ◽

2002 ◽

Vol 56 (3) ◽

pp. 335-346 ◽

Cited By ~ 6

Author(s):

Diana S. Woodruff-Pak

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Acetylcholine Receptors ◽

Nicotinic Acetylcholine ◽

Cognition Enhancement

P1-070: Absence of α7 nicotinic acetylcholine receptors (α7nAChR) improve cognitive deficits and dendritic pathology in a mouse model of Alzheimer's disease (AD)

Alzheimer s & Dementia ◽

10.1016/j.jalz.2008.05.656 ◽

2008 ◽

Vol 4 ◽

pp. T226-T227

Author(s):

Gustavo Dziewczapolski ◽

Carolina Glogowski ◽

Eliezer Masliah ◽

Stephen F. Heinemann

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Mouse Model ◽

Cognitive Deficits ◽

Α7 Nicotinic Acetylcholine Receptors

Acetylcholine Receptors ◽

Nicotinic Acetylcholine ◽

Model Of Alzheimer’S Disease ◽

P.1.022 Amyloid aggregation is critical for the interaction with neuronal nicotinic acetylcholine receptors (nAChRs) – implications for neuroprotection in Alzheimer's disease

European Neuropsychopharmacology ◽

10.1016/s0924-977x(10)70024-9 ◽

2010 ◽

Vol 20 ◽

pp. S19-S20

Author(s):

A.M. Lilja ◽

O. Porras ◽

E. Storelli ◽

A. Nordberg ◽

A. Marutle

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Acetylcholine Receptors ◽

Neuronal Nicotinic Acetylcholine Receptors ◽

Amyloid Aggregation ◽

Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade

Neuropharmacology ◽

10.1016/j.neuropharm.2006.04.007 ◽

2006 ◽

Vol 51 (3) ◽

pp. 474-486 ◽

Cited By ~ 125

Author(s):

Yuki Takada-Takatori ◽

Toshiaki Kume ◽

Mitsuhiro Sugimoto ◽

Hiroshi Katsuki ◽

Hachiro Sugimoto ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Acetylcholine Receptors ◽

Acetylcholinesterase Inhibitors ◽

Phosphatidylinositol 3 Kinase ◽

Nicotinic Acetylcholine ◽

Glutamate Neurotoxicity ◽

Kinase Cascade ◽

Phosphatidylinositol 3